Treatment of mediastinal fibrosis with mycophenolate mofetil.


Autoria(s): Witschi M.; Gugger M.; Nicod L.P.
Data(s)

2009

Resumo

We present the case of a 67-year-old male patient with mediastinal and retroperitoneal fibrosis. In Europe, this is a rare disease. Treatment was established to prevent complications due to strictures or compressions. Because of his diabetes, a therapy of low-dose prednisone combined with mycophenolate mofetil, known as steroid sparing agent, was applied. As a result, the radiological follow-up showed a marked decrease in the mediastinal and retroperitoneal masses.

Identificador

http://serval.unil.ch/?id=serval:BIB_7C8172B07487

isbn:1423-0356[electronic]

pmid:19295189

doi:10.1159/000209508

isiid:000268894700015

Idioma(s)

en

Fonte

Respiration, vol. 78, no. 3, pp. 330-333

Tipo

info:eu-repo/semantics/article

article